A. Dehghani, A. Tabaku, and S. Eshghjoo, “The tricyclic antidepressant amitriptyline is cytotoxic to hjuman breast cancer (MCF7) cells”, JBS, vol. 5, no. 1, pp. 85–92, Apr. 2022.